SPCC24B10.02c Antibody

What is SPCC24B10.02c and why is it significant for antibody-based research?

SPCC24B10.02c is an uncharacterized kinase from Schizosaccharomyces pombe (strain 972), also identified as UniProt accession Q9P7K3. It represents an important research target as a member of the kinase family in fission yeast. The protein is significant for studying post-translational modifications, particularly phosphorylation events, as it contains documented phosphorylation sites at S110, S416, and S420 . Antibodies against this protein enable researchers to investigate its subcellular localization, protein-protein interactions, and functional roles during various cellular processes, despite its current "uncharacterized" status.

What are the known post-translational modifications of SPCC24B10.02c that antibodies might detect?

Based on the available data, SPCC24B10.02c undergoes phosphorylation at multiple sites. Specifically, phosphorylation has been documented at:

When selecting or developing antibodies, researchers should consider whether they need antibodies that detect the protein regardless of its phosphorylation state (total protein antibodies) or phospho-specific antibodies that only recognize the protein when phosphorylated at specific residues .

How does the structure of SPCC24B10.02c influence antibody development strategies?

While the search results don't provide detailed structural information about SPCC24B10.02c, general principles of antibody development apply. Researchers should identify unique, surface-exposed epitopes that are likely accessible in the protein's native conformation. The documented phosphorylation sites (S110, S416, S420) indicate regions that may undergo conformational changes . When developing antibodies, these regions should be carefully considered, as antibodies targeting these areas might be affected by the phosphorylation state. Additionally, comparative sequence analysis with related proteins should be conducted to ensure antibody specificity and minimize cross-reactivity with related kinases.

What are the optimal fixation and permeabilization methods for immunodetection of SPCC24B10.02c in S. pombe cells?

For successful immunodetection of SPCC24B10.02c in S. pombe cells, researchers should consider the challenging nature of working with yeast cell walls. Effective protocols typically involve:

• Fixation with 3.7-4% formaldehyde for 30 minutes at room temperature

• Cell wall digestion with zymolyase or lysing enzymes (1mg/ml in sorbitol buffer)

• Permeabilization with 0.1% Triton X-100 for 5 minutes

This approach preserves protein epitopes while providing antibody access to intracellular structures. For phospho-specific detection, phosphatase inhibitors (like sodium orthovanadate, sodium fluoride) should be included in all buffers to preserve the phosphorylation state .

How should researchers validate the specificity of SPCC24B10.02c antibodies?

Validation of antibody specificity for SPCC24B10.02c should include multiple complementary approaches:

• Western blot analysis comparing wild-type strains with SPCC24B10.02c deletion mutants

• Peptide competition assays using the immunizing peptide

• RNA interference or CRISPR knockout controls

• Immunoprecipitation followed by mass spectrometry to confirm target identity

• Cross-reactivity testing against related kinases

For phospho-specific antibodies, additional validation should include treatment with phosphatases to demonstrate phosphorylation-dependent recognition. The SPOT peptide assay layout with appropriate controls, similar to methods used for SH3 domain studies, can be adapted for epitope mapping and specificity testing .

What controls are essential when designing immunoprecipitation experiments with SPCC24B10.02c antibodies?

When designing immunoprecipitation (IP) experiments for SPCC24B10.02c, researchers should implement these critical controls:

• Negative controls:

  • IPs with non-specific IgG of the same species as the SPCC24B10.02c antibody

  • IPs from SPCC24B10.02c deletion strains using the specific antibody

• Positive controls:

  • IP of known interaction partners (if established)

  • IP of epitope-tagged versions of SPCC24B10.02c using tag-specific antibodies

• Technical controls:

  • Input sample (pre-IP lysate) to verify protein expression

  • Unbound fraction to assess IP efficiency

  • Beads-only control to identify non-specific binding

For phosphorylation studies, researchers should include phosphatase-treated samples as additional controls to demonstrate specificity of phospho-antibodies .

How can researchers overcome the challenges of low endogenous expression of SPCC24B10.02c?

Working with low-abundance proteins like uncharacterized kinases can be challenging. Researchers can employ several strategies to improve detection:

• Enrichment techniques:

  • Use of nmt1 promoter-based overexpression systems for S. pombe

  • Subcellular fractionation to concentrate specific cellular compartments

  • Immunoprecipitation followed by western blotting rather than direct detection

• Signal amplification:

  • Tyramide signal amplification for immunofluorescence

  • Enhanced chemiluminescence substrates for western blotting

  • Poly-HRP conjugated secondary antibodies

• Alternative detection methods:

  • Mass spectrometry-based approaches for protein identification

  • Proximity ligation assays for detecting protein-protein interactions

  • CRISPR-based tagging with bright fluorescent proteins

When attempting to detect native SPCC24B10.02c, it's important to optimize lysis conditions to ensure complete protein extraction while preserving epitope structure .

What are the main pitfalls when using phospho-specific antibodies against SPCC24B10.02c?

When working with phospho-specific antibodies against SPCC24B10.02c, researchers should be aware of several common challenges:

• Phosphorylation dynamics: The S110, S416, and S420 phosphorylation sites may be transiently modified depending on cell cycle stage or stress conditions, making consistent detection difficult .

• Phosphatase activity: Endogenous phosphatases can rapidly dephosphorylate sites during sample preparation. Always include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in all buffers.

• Epitope masking: Phosphorylation can alter protein conformation or create binding sites for interacting proteins, potentially blocking antibody access.

• Cross-reactivity: Phospho-motifs may be similar across multiple kinases, requiring careful validation to ensure specificity.

• Quantification challenges: When comparing phosphorylation levels, always normalize to total protein levels detected with a phosphorylation-independent antibody.

To address these issues, researchers should consider using complementary approaches like Phos-tag gels or mass spectrometry to validate phosphorylation-dependent results .

How can researchers optimize antibody concentration for Western blot detection of SPCC24B10.02c?

Optimization of antibody concentrations for Western blot detection of SPCC24B10.02c should follow a systematic approach:

• Initial titration experiment:

  • Test a wide range of primary antibody dilutions (1:100 to 1:10,000)

  • Keep secondary antibody concentration constant (typically 1:5,000)

  • Include positive controls (if available) and molecular weight markers

• Signal-to-noise evaluation:

  • Select the dilution that provides the best balance between specific signal and background

  • Consider using gradient gels to better resolve the target protein

  • Implement blocking optimization (test different blockers like BSA, milk, commercial blockers)

• Fine-tuning:

  • Adjust incubation times (1 hour at room temperature vs. overnight at 4°C)

  • Test different detection substrates based on protein abundance

  • Consider membrane type (PVDF vs. nitrocellulose) based on protein size and hydrophobicity

For phospho-specific antibodies, additional optimization may include lambda phosphatase controls and comparison of different lysis buffers to preserve phosphorylation states .

How can SPCC24B10.02c antibodies be utilized in protein interaction studies involving SH3 domains?

SPCC24B10.02c antibodies can be valuable tools for investigating potential interactions with SH3 domain-containing proteins in fission yeast. Building on approaches used in similar studies:

• Co-immunoprecipitation assays:

  • Use SPCC24B10.02c antibodies to pull down the protein and its interacting partners

  • Probe for specific SH3 domain proteins in the immunoprecipitate

  • Validate interactions with reciprocal IPs using antibodies against potential SH3 partners

• Proximity-based approaches:

  • Implement BioID or APEX2 proximity labeling coupled with SPCC24B10.02c antibodies

  • Use FRET or FLIM with antibody-based detection to evaluate direct interactions

• Peptide array analysis:

  • Similar to the SPOT peptide arrays described for SH3 domain studies, create arrays of SPCC24B10.02c-derived peptides

  • Test binding of various SH3 domains to these peptides

  • Use antibodies to detect bound proteins or to validate peptide identity

• Yeast two-hybrid validation:

  • After identifying potential interactions, validate them using techniques similar to those used for Rvs167 binding specificity studies

  • Create constructs expressing regions of SPCC24B10.02c and test against SH3 domain libraries

What approaches can be used to study the dynamics of SPCC24B10.02c phosphorylation during the cell cycle?

To study the dynamics of SPCC24B10.02c phosphorylation across the cell cycle, researchers can employ several complementary approaches:

• Synchronization combined with time-course analysis:

  • Synchronize S. pombe cells using methods like nitrogen starvation-release or hydroxyurea block

  • Collect samples at defined time points across the cell cycle

  • Use phospho-specific antibodies against S110, S416, and S420 to track modification patterns

  • Simultaneously track cell cycle progression with established markers

• Live-cell imaging approaches:

  • Generate phospho-binding domains fused to fluorescent proteins

  • Use FRET-based biosensors to monitor SPCC24B10.02c phosphorylation in real-time

  • Correlate phosphorylation changes with cell cycle events

• Quantitative phosphoproteomics:

  • Implement SILAC or TMT labeling for quantitative mass spectrometry

  • Compare phosphopeptide abundance across cell cycle stages

  • Validate findings using phospho-specific antibodies

• Genetic approaches:

  • Generate phospho-mimetic (S→D/E) and phospho-deficient (S→A) mutants of S110, S416, and S420

  • Use antibodies to study the localization and interaction patterns of these mutants

  • Correlate with phenotypic analyses to determine functional significance

How can super-resolution microscopy be combined with SPCC24B10.02c antibodies to reveal subcellular localization patterns?

Super-resolution microscopy offers powerful approaches for precise localization of SPCC24B10.02c when combined with optimized antibody-based detection:

• Sample preparation optimization:

  • Test different fixation methods (formaldehyde, methanol, or combined approaches)

  • Optimize permeabilization to maintain cellular architecture while allowing antibody access

  • Consider cell wall digestion parameters carefully for S. pombe

• Technical approaches:

  • STORM/PALM: Use directly conjugated primary antibodies or secondary antibodies with appropriate fluorophores (Alexa 647, Cy5)

  • SIM: Implement structured illumination microscopy for ~100nm resolution with standard immunofluorescence protocols

  • STED: Utilize stimulated emission depletion microscopy with appropriate fluorophores (ATTO647N, STAR635P)

• Multi-color imaging strategies:

  • Combine SPCC24B10.02c antibody labeling with markers for cellular structures

  • Use organelle markers to determine precise subcellular localization

  • Apply sequential imaging protocols for multi-color super-resolution

• Quantitative analysis:

  • Implement cluster analysis to identify potential protein complexes

  • Use distance measurements between SPCC24B10.02c and cellular landmarks

  • Apply colocalization analysis with known interacting partners

How should researchers interpret SPCC24B10.02c detection across different experimental conditions?

When analyzing SPCC24B10.02c detection across experimental conditions, researchers should implement a systematic interpretation framework:

• Quantitative comparison strategies:

  • Normalize SPCC24B10.02c signal to appropriate loading controls (tubulin, actin)

  • For phosphorylation studies, calculate the ratio of phospho-signal to total protein

  • Use at least three biological replicates for statistical validation

• Expression pattern analysis:

  • Consider cell cycle-dependent changes in expression or localization

  • Evaluate stress responses that might affect kinase activity

  • Assess potential post-translational modifications beyond phosphorylation

• Contextual interpretation:

  • Compare results with known kinases in the same family

  • Consider the impact of experimental manipulations on kinase activation

  • Integrate findings with existing knowledge of S. pombe signaling networks

• Addressing conflicting data:

  • When results differ between detection methods, prioritize orthogonal validation

  • Consider antibody-specific limitations (epitope accessibility, specificity)

  • Evaluate potential artifacts introduced by sample preparation

What statistical approaches are appropriate for analyzing phosphorylation data from SPCC24B10.02c antibody studies?

When analyzing phosphorylation data from SPCC24B10.02c antibody-based studies, appropriate statistical approaches include:

• For Western blot quantification:

  • Implement two-way ANOVA to assess factors like treatment and time

  • Use post-hoc tests (Tukey, Bonferroni) for multiple comparisons

  • Apply repeated measures designs when tracking changes over time

  • Consider non-parametric alternatives when normality assumptions are violated

• For microscopy-based quantification:

  • Use mixed-effects models to account for cell-to-cell variability

  • Implement intensity correlation analysis for colocalization studies

  • Apply Ripley's K function or similar approaches for cluster analysis

• For large-scale phosphoproteomics:

  • Employ specialized statistical frameworks like limma or MSstats

  • Implement multiple testing correction (Benjamini-Hochberg) as used in the SH3 domain study

  • Consider phosphosite-specific variance when comparing across sites

• Visualization approaches:

  • Create volcano plots to visualize significant changes in phosphorylation

  • Use heatmaps to compare patterns across conditions and phosphosites

  • Implement PCA or t-SNE for dimensionality reduction with multiple phosphosites

How can phospho-specific antibody data be integrated with other functional genomics approaches in SPCC24B10.02c studies?

Integrating phospho-specific antibody data with other functional genomics approaches provides comprehensive insights into SPCC24B10.02c function:

• Integration with transcriptomics:

  • Correlate SPCC24B10.02c phosphorylation states with gene expression changes

  • Identify potential transcriptional targets regulated by kinase activity

  • Use pathway enrichment analysis to identify biological processes affected

• Correlation with phenotypic data:

  • Link phosphorylation patterns to cellular phenotypes in deletion or mutation strains

  • Assess the impact of kinase inhibitors on both phosphorylation and phenotype

  • Develop predictive models connecting phosphorylation states to functional outcomes

• Network analysis approaches:

  • Map SPCC24B10.02c phosphorylation data onto protein interaction networks

  • Identify signaling modules that might be co-regulated

  • Apply algorithms to infer causal relationships in signaling cascades

• Multi-omics data integration:

  • Implement Bayesian integration frameworks

  • Use supervised machine learning to identify patterns across data types

  • Apply knowledge graph approaches to connect phosphorylation events to biological functions

These integrated approaches help contextualize antibody-derived phosphorylation data within broader cellular processes and regulatory networks .